Pulmonx (LUNG) Change in Accured Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Accured Expenses data on file, last reported at $528000.0 in Q3 2025.

• Change in Accured Expenses for Q3 2025 came in at $528000.0, down 27.87% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.1 million (up 269.71% YoY), and the FY2024 annual result was $462000.0, down 85.45% from the prior year.
• Change in Accured Expenses declined to $528000.0 in Q3 2025 per LUNG's latest filing, from $2.5 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $4.0 million in Q4 2024 and troughed at -$6.0 million in Q1 2024.
• A 5-year average of $355315.8 and a median of $1.0 million in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses soared 237.32% in 2021, then sank 357.53% in 2022.
• A 5-year view of Change in Accured Expenses shows it stood at $1.5 million in 2021, then jumped by 58.05% to $2.4 million in 2022, then retreated by 5.53% to $2.3 million in 2023, then jumped by 76.48% to $4.0 million in 2024, then slumped by 86.72% to $528000.0 in 2025.
• Business Quant data shows LUNG's Change in Accured Expenses at $528000.0 in Q3 2025, $2.5 million in Q2 2025, and -$4.9 million in Q1 2025.